Page last updated: 2024-09-05

zm 241385 and 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine

zm 241385 has been researched along with 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine in 6 studies

Compound Research Comparison

Studies (zm 241385)	Trials (zm 241385)	Recent Studies (post-2010) (zm 241385)	Studies (2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine)	Trials (2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine)	Recent Studies (post-2010) (2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine)
401	3	124	23	0	15

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (66.67)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Andrews, SP; Congreve, M; Errey, JC; Marshall, FH; Mason, JS; Robertson, N; Tehan, B; Weir, M; Zhukov, A	1
de Lera Ruiz, M; Lim, YH; Zheng, J	1
French, SW; Khachatoorian, R; Micewicz, ED; Ruchala, P	1
Agouridas, L; Duroux, R; El Bakali, J; Furman, C; Melnyk, P; Renault, N; Yous, S	1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G	1
Barczyk, A; Bolteau, R; Cherezov, V; Coevoet, M; Duroux, R; Han, GW; Laversin, A; Liberelle, M; Melnyk, P; Ravez, S; Renault, N; Shiriaeva, A; Stauch, B; Vreulz, B; Yous, S	1

Reviews

2 review(s) available for zm 241385 and 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine

Article	Year
Adenosine A2A receptor as a drug discovery target. Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction	2014
Adenosine receptor antagonists: Recent advances and therapeutic perspective. European journal of medicinal chemistry, 2022, Jan-05, Volume: 227 Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship	2022

Other Studies

4 other study(ies) available for zm 241385 and 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7h-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine

Article	Year
Biophysical mapping of the adenosine A2A receptor. Journal of medicinal chemistry, 2011, Jul-14, Volume: 54, Issue:13 Topics: Adenosine A2 Receptor Antagonists; Binding Sites; Drug Design; Ligands; Models, Molecular; Mutation; Pyrimidines; Receptor, Adenosine A2A; Small Molecule Libraries; Triazines; Triazoles; Xanthines	2011
Identification of novel small-molecule inhibitors of Zika virus infection. Bioorganic & medicinal chemistry letters, 2018, 02-01, Volume: 28, Issue:3 Topics: A549 Cells; Antiviral Agents; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Zika Virus; Zika Virus Infection	2018
Antagonists of the adenosine A European journal of medicinal chemistry, 2018, Jan-20, Volume: 144 Topics: Adenosine A2 Receptor Antagonists; Benzoxazoles; Caco-2 Cells; Cell Line, Tumor; Drug Design; Humans; Microsomes, Liver; Receptor, Adenosine A2A; Solubility	2018
High ligand efficiency quinazoline compounds as novel A European journal of medicinal chemistry, 2022, Nov-05, Volume: 241 Topics: Adenosine A2 Receptor Antagonists; Ligands; Molecular Docking Simulation; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Structure-Activity Relationship	2022